Catalent Inc (CTLT)
60.33
+0.04
(+0.07%)
USD |
NYSE |
Sep 27, 16:00
60.31
-0.02
(-0.03%)
After-Hours: 20:00
Catalent Free Cash Flow: -59.00M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -59.00M |
| March 31, 2024 | -123.00M |
| December 31, 2023 | -263.00M |
| September 30, 2023 | -235.00M |
| June 30, 2023 | -322.00M |
| March 31, 2023 | -563.00M |
| December 31, 2022 | -371.00M |
| September 30, 2022 | -471.00M |
| June 30, 2022 | -221.00M |
| March 31, 2022 | -110.00M |
| December 31, 2021 | -183.00M |
| September 30, 2021 | -244.00M |
| June 30, 2021 | -253.00M |
| March 31, 2021 | -188.10M |
| December 31, 2020 | -134.70M |
| September 30, 2020 | 22.30M |
| June 30, 2020 | -26.00M |
| March 31, 2020 | -36.40M |
| December 31, 2019 | 20.50M |
| September 30, 2019 | -21.20M |
| June 30, 2019 | 30.00M |
| March 31, 2019 | 75.00M |
| December 31, 2018 | 108.10M |
| Date | Value |
|---|---|
| September 30, 2018 | 159.90M |
| June 30, 2018 | 198.00M |
| March 31, 2018 | 201.70M |
| December 31, 2017 | 210.90M |
| September 30, 2017 | 180.10M |
| June 30, 2017 | 159.70M |
| March 31, 2017 | 113.60M |
| December 31, 2016 | 68.60M |
| September 30, 2016 | 24.60M |
| June 30, 2016 | 15.70M |
| March 31, 2016 | 58.40M |
| December 31, 2015 | 90.70M |
| September 30, 2015 | 113.50M |
| June 30, 2015 | 30.80M |
| March 31, 2015 | 10.60M |
| December 31, 2014 | -15.60M |
| September 30, 2014 | -21.50M |
| June 30, 2014 | 55.90M |
| March 31, 2014 | 48.10M |
| December 31, 2013 | 42.90M |
| September 30, 2013 | 34.10M |
| June 30, 2013 | 15.20M |
Free Cash Flow Range, Past 5 Years
-563.00M
Minimum
Mar 2023
22.30M
Maximum
Sep 2020
-189.08M
Average
-185.55M
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp | 877.90M |
| The Cooper Companies Inc | 189.20M |
| Johnson & Johnson | 19.83B |
| Merck & Co Inc | 13.15B |
| BioCardia Inc | -7.108M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 214.00M |
| Cash from Investing (Quarterly) | -74.00M |
| Cash from Financing (Quarterly) | -10.00M |
| Free Cash Flow Per Share (Quarterly) | 0.768 |
| Free Cash Flow to Equity (Quarterly) | 214.00M |
| Free Cash Flow to Firm (Quarterly) | 178.34M |
| Free Cash Flow Yield | -0.54% |